During the past decade, Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center" #1 sponsor was "Children's Oncology Group" with 35 trials, followed by "NSABP Foundation Inc" with 5 trials sponsored, "Eastern Cooperative Oncology Group" with 2 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored and "SWOG Cancer Research Network" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 44 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Children's Oncology Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center" are "Sarcoma" (10 trials), "Leukemia" (8 trials), "Breast Cancer" (5 trials), "Central Nervous System Tumors" (5 trials) and "Neuroblastoma" (5 trials). Many other conditions were trialed in "Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center" in a lesser frequency.

Most popular intervention types in "Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center" are "Drug" (39 trials), "Biological" (20 trials), "Radiation" (17 trials), "Procedure" (15 trials) and "Genetic" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (18 trials), "filgrastim" (16 trials), "radiation therapy" (16 trials), "etoposide" (15 trials) and "vincristine sulfate" (15 trials). Other intervention names were less common.

The vast majority of trials in "Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center" are 39 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, 3 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".